Drug safety : preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

Bibliographic Details
Main Author: Crosse, Marcia
Corporate Authors: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, United States. Government Accountability Office
Format: Government Document eBook
Language:English
Published: [Washington, D.C.] : U.S. Govt. Accountability Office, [2008]
Series:Testimony ; GAO-08-701 T.
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS94734
Description
Item Description:Title from title screen (viewed on May 29, 2008).
"For release ... April 22, 2008."
Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
Electronic resource.
Physical Description:19 pages : digital, PDF file.
Format:Mode of access: Internet from GPO Access web site. Address as of 5/29/08: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=gao&docid=f:d08701t.pdf ; current access available via PURL.
Bibliography:Includes bibliographical references.